Money
Strait of Hormuz Standoff Threatens U.S. Generic Drug Supply Chain
With half of U.S. generic drugs produced in India and passing through the Strait of Hormuz, current geopolitical tensions raise concerns over supply chain integrity and stockpile adequacy.
Editorial Staff
1 min read
The Strait of Hormuz is a critical transit route for pharmaceuticals, particularly for generic drugs produced in India, which account for half of the U.S. supply.
Recent geopolitical tensions in the region have prompted supply chain analysts to assess the potential impacts on drug availability and distribution.
While supply chains are typically designed to handle emergencies, current stockpiles of prescription medications are reported to be limited, raising concerns about future accessibility.